News
-
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
BIOPHYTIS REPORTS ITS PROVISIONAL FINANCIAL RESULTS AND PROVIDES ITS STRATEGIC OUTLOOK
Biophytis reports provisional financial results for fiscal year 2025 and strategic outlook, including milestones in sarcopenia and obesity programs, engagement with scientific community, and financial restructuring -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Biophytis annonce la suspension provisoire de la cotation de son action
Biophytis annonce la suspension provisoire de la cotation de son action sur Euronext en raison du retard de publication du rapport financier annuel 2025. Reprise de la cotation prévue après certification des comptes -
COMMUNIQUÉ DE PRESSE
BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Biophytis announces the temporary suspension of the trading of its shares on Euronext Growth Paris due to a delay in publishing the annual financial report. Trading expected to resume post-report certification